Southern Acids (M) Stock price

Equities

SAB

MYL5134OO001

Commodity Chemicals

End-of-day quote BURSA MALAYSIA 07:00:00 2024-03-24 pm EDT 5-day change 1st Jan Change
3.2 MYR -0.31% Intraday chart for Southern Acids (M) -0.31% +1.59%
Sales 2022 1.18B 250M Sales 2023 1.11B 234M Capitalization 493M 104M
Net income 2022 94M 19.87M Net income 2023 33M 6.98M EV / Sales 2022 0.19 x
Net cash position 2022 297M 62.78M Net cash position 2023 379M 80.03M EV / Sales 2023 0.1 x
P/E ratio 2022
5.58 x
P/E ratio 2023
14.8 x
Employees 1,737
Yield 2022
1.3%
Yield 2023
1.39%
Free-Float 25.53%
More Fundamentals * Assessed data
Dynamic Chart
Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Independent Director to Non Independent and Non Executive Director CI
Southern Acids (M) Berhad Announces Production Results for the Month of February 2024 CI
Southern Acids (M) Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Southern Acids (M) Berhad Announces Redesignation of Stephen Wan Yeng Leong from Member of Audit Committee to Independent and Non Executive Chairman of Audit Committee CI
Southern Acids (M) Berhad Announces Cessation of Office of Tan Sri Datuk Seri Panglima Sulong Bin Matjeraie as Independent and Non Executive Member of Audit Committee CI
Southern Acids (M) Berhad Announces Redesignation of Chung Kin Mun from Chairman of Audit Committee to Independent and Non Executive Member of Audit Committee CI
Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Member of Audit Committee CI
Southern Acids (M) Berhad Reports Production Results for the Month of January 2024 CI
Southern Acids (M) Berhad Reports Production Results for the Month of December 2023 CI
Southern Acids (M) Berhad Reports Production Results for the Month of November 2023 CI
Southern Acids (M) Berhad Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Southern Acids (M) Berhad Reports Production Results for the Month of October 2023 CI
Southern Acids (M) Berhad Reports Production Results for the Month of September 2023 CI
Southern Acids (M) Berhad Reports Production Results for the Month of August 2023 CI
Southern Acids (M) Berhad Announces Appointment of Deborah Deb-Bie Choa as Independent and Non Executive Director CI
More news
1 day-0.31%
1 week-0.31%
Current month-2.14%
1 month-2.14%
3 months+0.95%
6 months-5.60%
Current year+1.59%
More quotes
1 week
3.20
Extreme 3.2
3.21
1 month
3.18
Extreme 3.18
3.27
Current year
3.15
Extreme 3.15
3.41
1 year
3.12
Extreme 3.12
3.65
3 years
3.12
Extreme 3.12
4.30
5 years
2.70
Extreme 2.7
4.30
10 years
2.70
Extreme 2.7
5.98
More quotes
Managers TitleAgeSince
Chief Executive Officer 45 -
Director of Finance/CFO 56 13-09-30
Chief Tech/Sci/R&D Officer 36 14-07-15
Members of the board TitleAgeSince
Director/Board Member 64 -
Director/Board Member 57 12-03-19
Director of Finance/CFO 56 13-09-30
More insiders
Date Price Change Volume
24-03-25 3.2 -0.31% 4,000
24-03-22 3.21 0.00% 1,500
24-03-20 3.21 -0.31% 20,500
24-03-19 3.22 0.00% 1,000

End-of-day quote BURSA MALAYSIA, March 24, 2024

More quotes
Southern Acids (M) Berhad is a Malaysia-based company, which is engaged in manufacturing of oleochemical products. The Company operates through three segments: Oleochemical, Milling & Estate, and Healthcare. The Oleochemical segment is involved in the manufacturing and marketing of fatty acids and glycerin with a production mix ratio of approximately 90:10 between fatty acids and glycerin. The manufacturing plant is located in Kapar, Klang, which has an annual manufacturing capacity of approximately 100,000 metric tons (MT). The Milling & Estate Segment is principally engaged in the processing of fresh fruit bunches (FFB) into crude palm oil (POM) and palm kernel, as well as oil palm cultivation. It operates two POM located in Riau, Indonesia with a combined milling capacity of 100 MT per hour. The Healthcare Segment operates Sri Kota Specialist Medical Centre (Sri Kota), a 232-bedded private tertiary hospital located in Klang, Selangor.
More about the company
  1. Stock
  2. Equities
  3. Stock Southern Acids (M) - BURSA MALAYSIA